Table 1.
Patient and disease characteristics at baseline
| Arm A (n = 40) | Arm B (n = 41) | |||
| n | (%) | n | (%) | |
| Received treatment | 39 | (97.5) | 38 | (92.7) |
| Age, years | ||||
| Median (range) | 63 (35–77) | 63 (48–74) | ||
| Gender | ||||
| Male | 33 | (82.5) | 32 | (78.0) |
| Female | 7 | (17.5) | 9 | (22.0) |
| ECOG performance status | ||||
| 0 | 19 | (47.5) | 20 | (48.8) |
| 1 | 16 | (40) | 16 | (39) |
| 2 | 4 | (10) | 3 | (7.3) |
| Missing | 1 | (2.5) | 2 | (4.9) |
| Histological classification | ||||
| Adenocarcinoma | 22 | (55) | 23 | (56.1) |
| Epidermoidal carcinoma | 14 | (35) | 12 | (29.3) |
| Other NSCLC | 4 | (10) | 6 | (14.6) |
| Site of disease | ||||
| Lung ± lymph nodes | 14 | (35) | 14 | (34.1) |
| Lung and 1 metastatic site | 12 | (30) | 15 | (36.6) |
| Lung and ≥ 2 metastatic sites | 9 | (22.5) | 10 | (24.4) |
| Extra-pulmonary disease | 5 | (12.5) | 2 | (4.9) |
| Previous surgery for neoplastic disease | ||||
| Yes | 4 | (10) | 5 | (13) |
| Palliative | 4 | 2 | ||
| Curative | 0 | 3 | ||
| No | 35 | (90) | 33 | (87) |